The acquisition brings Halda's candidate HLD-0915, a clinical-stage treatment for prostate cancer, into J&J's oncology ...

Johnson & Johnson acquires Halda Therapeutics for $3 billion to strengthen its oncology portfolio, focusing on prostate ...

Johnson & Johnson has agreed to acquire Halda Therapeutics for $3.05 billion cash, in a deal designed to expand the buyer’s cancer pipeline with Halda’s precision oncology candidates, led by a ...

J&J's $3.05B move for Halda adds targeted oral cancer therapies and expands its prostate cancer pipeline amid rising pharma M&A.

Akzo Nobel NV has agreed to acquire smaller rival paint maker Axalta Coating Systems Ltd in a cross-border deal creating a ...

Johnson & Johnson ( JNJ) rose 0.27% to close at $200.12 on Tuesday, marking the seventh consecutive session of gains. An analyst said the company's prospects are helped by strong Q3 results and ...

Novo Nordisk to lower cash-pay prices for Ozempic and Wegovy to $349 a month; J&J buys Halda Therapeutics for $3.05 billion; Trump attacking health insurers underscores rising tensions around ...

Dow Jones Top Company Headlines at 5 AM ET: Baidu Revenue Falls on Weak Advertising Demand, Posts Loss on Impairment | AkzoNobel, ... Baidu Revenue Falls on Weak Advertising Demand, Posts Loss on ...

Dow Jones Top Company Headlines at 3 AM ET: AkzoNobel, Axalta to Form $17 Billion Paints Giant in All-Stock Merger | Credit ... AkzoNobel, Axalta to Form $17 Billion Paints Giant in All-Stock Merger ...

Drugmakers are making notable deals, biotech is coming back, and much of the worry about tariffs and interest rates has faded ...

Johnson & Johnson (JNJ) rose 0.27% to close at $200.12 on Tuesday, marking the seventh consecutive session of gains. An analyst said the company's prospects are helped by strong Q3 results and ...

A new word is making the rounds in the business press: "anti-involution." In recent years, Chinese companies have built ...